SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001457612-16-000039
Filing Date
2016-02-04
Accepted
2016-02-04 16:31:06
Documents
1
Period of Report
2016-02-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_145462145482245.html 4  
1 FORM 4 wf-form4_145462145482245.xml 4 3879
  Complete submission text file 0001457612-16-000039.txt   5338
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Issuer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE, 5TH FLOOR CAMBRIDGE MA 02140
Business Address
Poole Jonathan (Reporting) CIK: 0001604689 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36289 | Film No.: 161388786